Loading…
Loading…
EQUITY / NYSE · XASE
CRYO-CELL International, Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →03/01/2026 – 05/31/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗3.99 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 3.99 USD · Volume 1,518
250 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
03/01/2026 – 05/31/2026 · Units
| Metric | 2026 / Quarter 2 | Prior year | Change |
|---|---|---|---|
| Operating profit | 1,197,341 USD | — | — |
| Net income | 554,586 USD | — | — |
| Cash and cash equivalents | 507,302 USD | — | — |
| Total liabilities | 78,463,962 USD | — | — |
| Total equity | -17,757,532 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 203/01/2026 – 05/31/2026ConsolidatedUnits · USD | 2026 / Quarter 212/01/2025 – 05/31/2026ConsolidatedUnits · USD | 2026 / Quarter 202/28/2026 – 02/28/2026ConsolidatedUnits · USD | 2026 / Quarter 112/01/2025 – 02/28/2026ConsolidatedUnits · USD | 2025 / Quarter 211/30/2025 – 11/30/2025ConsolidatedUnits · USD | 2025 / Year end12/01/2024 – 11/30/2025ConsolidatedUnits · USD | 2025 / Quarter 306/01/2025 – 08/31/2025ConsolidatedUnits · USD | 2025 / Quarter 312/01/2024 – 08/31/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 507,302 USD | — | — | 249,672 USD | 319,031 USD | 319,031 USD | 265,207 USD | — |
| Net incomeIncome statement | 554,586 USD | 601,694 USD | — | 47,108 USD | — | -2,429,385 USD | 749,408 USD | 1,388,048 USD |
| Operating profitIncome statement | 1,197,341 USD | 1,962,475 USD | — | 765,134 USD | — | 482,394 USD | 1,900,536 USD | 4,449,181 USD |
| Total assetsBalance sheet | 60,706,430 USD | — | — | 60,884,986 USD | 61,728,514 USD | 61,728,514 USD | 63,169,129 USD | — |
| Total equityBalance sheet | -17,757,532 USD | — | -18,400,272 USD | -18,400,272 USD | -18,605,929 USD | -18,605,929 USD | -14,831,399 USD | — |
| Total liabilitiesBalance sheet | 78,463,962 USD | — | — | 79,285,258 USD | 80,334,443 USD | 80,334,443 USD | 78,000,528 USD | — |
| Capital expendituresCash flow statement | — | 99,766 USD | — | 67,065 USD | — | 230,475 USD | — | 163,249 USD |
| Financing cash flowCash flow statement | — | -2,363,610 USD | — | -740,290 USD | — | -4,745,203 USD | — | -3,807,863 USD |
| Investing cash flowCash flow statement | — | 54,143 USD | — | 19,104 USD | — | -975,332 USD | — | -685,683 USD |
| Operating cash flowCash flow statement | — | 2,497,738 USD | — | 651,827 USD | — | 5,478,606 USD | — | 4,197,793 USD |
| Report source | Open report ↗ Published: 07/15/2026 | Open report ↗ Published: 07/15/2026 | Open report ↗ Published: 07/15/2026 | Open report ↗ Published: 04/14/2026 | Open report ↗ Published: 07/15/2026 | Open report ↗ Published: 02/27/2026 | Open report ↗ Published: 10/15/2025 | Open report ↗ Published: 10/15/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.